Catherine A. Reardon

10.3k citations

132 papers · 7.7k indexed · 3 hit papers · h-index 47

Immunology top 1%
- Atherosclerosis and Cardiovascular Diseases 36
Physiology top 1%
- Alzheimer's disease research and treatments 14
Endocrinology, Diabetes and Metabolism top 1%
- Diabetes, Cardiovascular Risks, and Lipoproteins 19
Surgery top 1%
- Cholesterol and Lipid Metabolism 35
- Lipoproteins and Cardiovascular Health 21
Cancer Research top 2%
- Cancer, Lipids, and Metabolism 12
Molecular Biology
- Peroxisome Proliferator-Activated Receptors 28
Epidemiology
- Adipokines, Inflammation, and Metabolic Diseases 27

Co-authors: Godfrey S. Getz Paul A. VanderLaan Mary Jo LaDu John R. Lukens Veneracion G. Cabana John M. Taylor T Mazzone Timothy J. Sontag
Cited by: Immunology Physiology Endocrinology, Diabetes and Metabolism
Journals: Science (1 paper)Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)
Partner nations: United States China Austria

In The Last Decade

Catherine A. Reardon

130 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Catherine A. Reardon

Since Specialization

Citations

This map shows the geographic impact of Catherine A. Reardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Reardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Reardon more than expected).

Fields of papers citing papers by Catherine A. Reardon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. Reardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Reardon. The network helps show where Catherine A. Reardon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Catherine A. Reardon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine A. Reardon Line = papers co-authored together Catherine A. Reardon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours Nature Nanotechnology ·Chang Cui,Kasturi Chakraborty,Xu Tang,Kelly Q. Schoenfelt,Alexandria Hoffman,Ariane Blank,Blake McBeth,Natalie Pulliam,Catherine A. Reardon,Swati Kulkarni,Tomáš Vaisar,Andrea Ballabio,Yamuna Krishnan,Lev Becker	2021	83
2	Obesity and Insulin Resistance Promote Atherosclerosis through an IFNγ-Regulated Macrophage Protein Network Cell Reports ·Catherine A. Reardon,Amulya Lingaraju,Kelly Q. Schoenfelt,Guolin Zhou,Chang Cui,Hannah Jacobs-El,Ilona Babenko,Andrew N. Hoofnagle,Daniel M. Czyż,Howard A. Shuman,Tomáš Vaisar,Lev Becker	2018	71
3	Plasminogen promotes cholesterol efflux by the ABCA1 pathway JCI Insight ·Nathalie Pamir,Patrick M. Hutchins,Graziella E. Ronsein,Wei Hao,Chongren Tang,Riku Das,Tomáš Vaisar,Edward F. Plow,Volker Schuster,Catherine A. Reardon,Richard B. Weinberg,David A. Dichek,Santica M. Marcovina,Godfrey S. Getz,Jay W. Heinecke	2017	36
4	Natural killer T cells in atherosclerosis Nature Reviews Cardiology ·Godfrey S. Getz,Catherine A. Reardon	2017	76
5	The western-type diet induces anti-HMGB1 autoimmunity in Apoe −/− mice Atherosclerosis ·Yue Pan,Hanzhong Ke,Zhaoqi Yan,Yajun Geng,Nathan Asner,Sunil Palani,Gnanasekar Munirathinam,Subramanyam Dasari,Karin C. Nitiss,Sarah A. Bliss,Priyanka Patel,Hongming Shen,Catherine A. Reardon,Godfrey S. Getz,Aoshuang Chen,Guoxing Zheng	2016	15
6	ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis Journal of Lipid Research ·Godfrey S. Getz,Catherine A. Reardon	2016	61
7	Polymorphisms of Mouse Apolipoprotein A-II Alter Its Physical and Functional Nature PLoS ONE ·Timothy J. Sontag,Catherine A. Reardon	2014	1
8	LIGHT/TNFSR14 Can Regulate Hepatic Lipase Expression by Hepatocytes Independent of T Cells and Kupffer Cells PLoS ONE ·Bijoy Chellan,Ekaterina P. Koroleva,Timothy J. Sontag,Alexei V. Tumanov,Yang‐Xin Fu,Godfrey S. Getz,Catherine A. Reardon	2013	9
9	A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR^–/– mice British Journal of Pharmacology ·Dacheng Peng,Richard A. Hiipakka,Jing‐Tian Xie,Qing Dai,John M. Kokontis,Catherine A. Reardon,Godfrey S. Getz,Shutsung Liao	2011	28
10	Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression Journal of the American College of Cardiology ·Sotirios Tsimikas,Atsushi Miyanohara,Karsten Hartvigsen,Esther Merki,Peter X. Shaw,Meng-Yun Chou,Jennifer Pattison,Michael Torzewski,Janina Sollors,Theodore Friedmann,N. Chin Lai,H. Kirk Hammond,Godfrey S. Getz,Catherine A. Reardon,Andrew C. Li,Carole L. Banka,Joseph L. Witztum	2011	91
11	HDL Apolipoprotein-Related Peptides in the Treatment of Atherosclerosis and other Inflammatory Disorders Current Pharmaceutical Design ·Godfrey S. Getz,Geoffrey D. Wool,Catherine A. Reardon	2010	28
12	Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties Journal of Lipid Research ·Geoffrey D. Wool,Catherine A. Reardon,Godfrey S. Getz	2008	58
13	Antiatherosclerotic Effects of a Novel Synthetic Tissue-Selective Steroidal Liver X Receptor Agonist in Low-Density Lipoprotein Receptor-Deficient Mice Journal of Pharmacology and Experimental Therapeutics ·Dacheng Peng,Richard A. Hiipakka,Qing Dai,Jian Guo,Catherine A. Reardon,Godfrey S. Getz,Shutsung Liao	2008	55
14	VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice Journal of Lipid Research ·Paul A. VanderLaan,Catherine A. Reardon,Ronald A. Thisted,Godfrey S. Getz	2008	52
15	Structure and Evolution of Human Apolipoprotein Genes: Identification of Regulatory Elements of the Human Apolipoprotein E Gene Novartis Foundation symposium ·John M. Taylor,Steve Lauer,Nabil A. Elshourbagy,Catherine A. Reardon,E Taxman,David Walker,David J. Chang,Young‐Ki Paik	2007	1
16	Novel proteasome inhibitors show potent anti-tumor efficacy Cancer Research ·K. Nomoto,Kozo Akasaka,Jiayi Wu,Erin Murphy,Yimin Jiang,Xiangyi Li,Karen TenDyke,Shawn Schiller,Catherine A. Reardon,Bruce Decosta,Christina J. Shaffer,Pamela D. McGuinness,Timothy Chamberlain,Huiming Zhang,Charles W. Johannes,Jean-Christophe Harmange,M W Vermeulen	2004	1
17	Lipoproteins produced by ApoE–/– astrocytes infected with adenovirus expressing human ApoE Journal of Neurochemistry ·Dacheng Peng,Ching Song,Catherine A. Reardon,Shutsung Liao,Godfrey S. Getz	2003	18
18	Mouse models of atherosclerosis Current Opinion in Lipidology ·Catherine A. Reardon,Godfrey S. Getz	2001	61
19	Characterization of an upstream regulatory sequence and its binding protein in the mouse apolipoprotein E gene Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Young‐Ki Paik,Catherine A. Reardon,John M. Taylor,Byung-Kwon Choi	1995	4
20	Effect of dietary lipids on plasma activity and hepatic mRNA levels of cholesteryl ester transfer protein in high-and low-responding baboons (Papio species) Metabolism ·Rampratap S. Kushwaha,Catherine A. Reardon,Douglas S. Lewis,Youlin Qi,Karen Rice,Godfrey S. Getz,K. Dee Carey,Henry C. McGill	1994	9

About Catherine A. Reardon

Catherine A. Reardon is a scholar working on Immunology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 132 papers that have together received 7.7k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (36 papers), Cholesterol and Lipid Metabolism (35 papers), Peroxisome Proliferator-Activated Receptors (28 papers), Adipokines, Inflammation, and Metabolic Diseases (27 papers), Lipoproteins and Cardiovascular Health (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Alzheimer's disease research and treatments (14 papers) and Cancer, Lipids, and Metabolism (12 papers). The work is most often cited by research in Immunology (2.0k citations), Physiology (1.9k citations) and Endocrinology, Diabetes and Metabolism (903 citations). Catherine A. Reardon has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Godfrey S. Getz, Paul A. VanderLaan, Mary Jo LaDu, John R. Lukens, Veneracion G. Cabana, John M. Taylor, T Mazzone, Timothy J. Sontag, Geoffrey D. Wool and Linda J. Van Eldik. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact